genprowebdirectory
GEN Edge
News
Insights
Trends for 2021
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
OMICs
From Genomes to Drugs: An Interview with Vertex CSO David Altshuler
Gene Therapy
AI Gets Gene Therapy Over the Immunity Hump
Coronavirus
Immunai Expands from Observational to Functional Genomics
Antibody Drug Conjugates
RNA in Its DNA: Avidity Biosciences Combines mAb Selectivity, Oligonucleotide Precision
Bioprocessing
OliX Advancing in Nucleic Acid Therapeutics
News
Cancer
Blocking a Treg Mechanism Can Scorch Tumors without Stoking Autoimmunity
Genome Editing
Now on Base, Rutgers Team Reveals New Genome Editing Approach
News
Phage Therapy Successful in Mice, but Resistance Looms
OMICs
Cellular Health Maintenance System Degradation May Lead to Advanced Huntington’s
News
Atopic Dermatitis Potentially Treated by Strain of Bacteria
Insights
All
Trends for 2021
Trends for 2020
Bioprocessing
COVID-19 Increasing Risk of Cyberattacks for Digital Biopharma
Bioprocessing
Case Study: How to Accelerate COVID-19 Vaccine Development
Bioprocessing
Flexibility is Key to Advances in Biomanufacturing
Bioprocessing
People Are Key to the Digital Evolution of Biopharma
A-Lists
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Cancer
Blocking a Treg Mechanism Can Scorch Tumors without Stoking Autoimmunity
OMICs
From Genomes to Drugs: An Interview with Vertex CSO David Altshuler
Upcoming Webinars
Solving Metadata Management from Sample Provenance through Omics
Bioprocessing
COVID-19 Increasing Risk of Cyberattacks for Digital Biopharma
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Cancer
Cervical Cancer
Cervical Cancer
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Cervical Cancer
Advaxis, Global BioPharma Ink Licensing Agreement for HPV Candidate
Cervical Cancer
Biomarker Could Predict HPV-Related Oropharyngeal Cancer Early On
Cervical Cancer
Scientists Say Discrete Population of Cells Gives Rise to High-Grade CIN, Cervical Cancer
Cervical Cancer
Roche Buys Mtm Labs for €130M Up Front for Cervical Cancer Diagnostics
Cervical Cancer
GSK Obtains FDA Nod for HPV Vaccine
Cervical Cancer
After Patient Dies, FDA Imposes Clinical Hold on Trial of Advaxis/AstraZeneca...
Cervical Cancer
Kite Pharma, bluebird bio Partner on Cancer Immunotherapies
Cervical Cancer
Inovio Expects to Net $23M from Direct Registered Offering to Single...
Cervical Cancer
FDA Clears Roche’s Cobas Assay for 14 HPV Genotypes
Cervical Cancer
MedImmune Licenses Inovio Cancer Vaccine for Up-to $727.5M
Cervical Cancer
Selecta Receives $3.2M from Skolkovo Foundation for Immuno-oncology Program
Cervical Cancer
FDA Lifts Hold on Start of Helix’ Trial for Topical Treatment...
Cervical Cancer
HPV Test for Resource-Poor Regions Approved in China
Cervical Cancer
Genticel to Shrink Workforce 30%
Cervical Cancer
Positive Phase III Results for Merck & Co.’s HPV Vaccine Candidate
1
2
3
...
5
Page 1 of 5
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Firm will use proceeds to fully fund Phase II trial with lead cervvcal cancer DNA vaccine.[Bobby4237-Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/UGENWebsitepicturesTopStoriesJan2011Jan24_2011_7994496_HandfulOfMoney_InovioFinancing2412559723-324x160.jpg "Inovio Expects to Net $23M from Direct Registered Offering to Single Investor")
![Firm says Mtm’s CINtec portfolio will complement cobas HPV assay.[© pressmaster - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/July18_2011_6312174_HandshakeWithEuroBackground_RocheBuysmtmlabs2627311515-265x198.jpg "Roche Buys Mtm Labs for €130M Up Front for Cervical Cancer Diagnostics")